Additional material
for journalists
Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.
News
| 15 Nov 2022 | |
| 13 Nov 2022 | |
| 07 Nov 2022 |
Events
| Event | When |
| Credit Suisse Healthcare Conference | November 7-10, 2022 |
| Jefferies Global Healthcare Conference | November 15-17, 2022 |
| Credit Suisse Equity Forum Switzerland | November 15-17, 2022 |
| J.P. Morgan Healthcare Conference |
January 9-12, 2023 |
| Baader Helvea Swiss Equities Conference |
January 11-13, 2023 |
|
Octavian Seminar
|
January 12-14, 2023 |
|
Full-Year 2022 Financial Results reporting*
|
February 7, 2023 |
|
First Quarter 2023 Financial Results reporting*
|
April 25, 2023 |
|
Annual General Meeting of Shareholders |
May 4, 2023 |
|
Half-Year 2023 Financial Results reporting* |
July 25, 2023 |
*We will be in a silent period for 10 days ahead of the financial reporting.
Stay informed
Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.
Social Media
Idorsia is active on social media – follow our channels to get a more personal view on the company.
Media center
Idorsia provides images, fact sheets and B-roll to download or support you with your article.
Contact
Andrew C. Weiss
Senior Vice President, Head of Investor Relations and Corporate Communications
Media Relations
Resources in German
Als schweizerisches Unternehmen stellen wir interessierten Personen auf dieser Seite wesentliche Informationen über unser Unternehmen in deutscher Sprache zur Verfügung.